Fenton Mary Kay

Avg. Two Year Performance

(27%) Avg. Purchase Return
(13%) Compound
58% Avg. Sale Return
26% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return5%(< 1%)23%(27%)(27%)
Purchase Success Rate1 of 10 of 11 of 10 of 10 of 1
Average Sale Return24%20%26%34%58%
Sale Success Rate4 of 54 of 54 of 53 of 53 of 5
Drugs » Biotechnology

Chief Financial Officer:

Holdings: 2.5K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Chief Financial Officer:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Chief Financial Officer:

Holdings: 68.05K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--